Alpha Synuclein Monomers

CAT:
400-SPR-316E
Size:
5x 100 µg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: Yes
Alpha Synuclein Monomers - image 1

Alpha Synuclein Monomers

  • Background:

    Alpha-Synuclein (SNCA) is expressed predominantly in the brain, where it is concentrated in presynaptic nerve terminals (1) . Alpha-synuclein is highly expressed in the mitochondria of the olfactory bulb, hippocampus, striatum and thalamus (2) . Functionally, it has been shown to significantly interact with tubulin (3), and may serve as a potential microtubule-associated protein. It has also been found to be essential for normal development of the cognitive functions; inactivation may lead to impaired spatial learning and working memory (4) . SNCA fibrillar aggregates represent the major non A-beta component of Alzheimers disease amyloid plaque, and a major component of Lewy body inclusions, and Parkinson's disease. Parkinson's disease (PD) is a common neurodegenerative disorder characterized by the progressive accumulation in selected neurons of protein inclusions containing alpha-synuclein and ubiquitin (5, 6) .
  • Description:

    Human Recombinant Alpha Synuclein Monomers (Type 2)
  • Product Name Alternative:

    Alpha synuclein monomer, Alpha-synuclein monomer, Alpha synuclein protein monomer, Alpha synuclein monomer, Alpha-synuclein protein, Non-A beta component of AD amyloid protein, Non-A4 component of amyloid precursor protein, NACP protein, SNCA protein, NACP protein, PARK1 protein, Alpha synuclein monomers, SYN protein, Parkinson disease familial 1 Protein
  • UNSPSC:

    12352202
  • UN Code:

    Non-hazardous
  • Hazard Statement:

    Non-hazardous
  • Gene ID:

    6622
  • Swiss Prot:

    P37840
  • Accession Number:

    NP_000336.1
  • Cellular Locus:

    Cytoplasm | Membrane | Nucleus
  • Expression System:

    E. coli
  • Host:

    E. coli
  • Origin Species:

    Human
  • Target:

    Alpha Synuclein
  • Conjugation:

    No tag
  • Nature:

    Recombinant
  • Sequence:

    MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVATVAEKTK EQVTNVGGAV VTGVTAVAQK TVEGAGSIAA ATGFVKKDQL GKNEEGAPQE GILEDMPVDP DNEAYEMPSE EGYQDYEPEA
  • Applications:

    WB | SDS-PAGE | In vivo assay | In vitro assay
  • Field of Research:

    Neuroscience | Neurodegeneration | Alzheimer's Disease | Tangles & Tau | Neuroscience | Neurodegeneration | Parkinson's Disease | Synuclein | Neuroscience | Neurodegeneration | Multiple System Atrophy
  • Purification Method:

    Ion-exchange Purified
  • Purification:

    Ion-exchange Purified
  • Limit Of Detection:

    Certified 95% pure using SDS-PAGE analysis. Low endotoxin <5 EU/mL @ 2mg/mL.
  • Concentration:

    2 mg/ml
  • Purity:

    >95%
  • Activity:

    Thioflavin T curve shows less β-sheet aggregation when Type 2 monomers (SPR-316) are seeded with PFFs compared to Type 1 monomers (SPR-321) seeded with PFFs.
  • Weight:

    0.05
  • Length:

    Full Length
  • Buffer:

    PBS pH 7.4
  • Molecular Weight:

    ~14.46 kDa
  • Precautions:

    Not for use in humans. Not for use in diagnostics or therapeutics. For research use only.
  • Additionnal Information:

    For corresponding PFFs, see catalog# SPR-317
  • References & Citations:

    1. “Genetics Home Reference: SNCA”. US National Library of Medicine. (2013). 2. Zhang L., et al. (2008) Brain Res. 1244: 40-52. 3. Alim M.A., et al. (2002) J Biol Chem. 277(3): 2112-2117. 4. Kokhan V.S., Afanasyeva M.A., Van'kin G. (2012) Behav. Brain. Res. 231(1): 226-230. 5. Spillantini M.G., et al. (1997) Nature. 388(6645): 839-840. 6. Mezey E., et al. (1998) Nat Med. 4(7): 755-757.
  • Shipping Conditions:

    Dry Ice. Shipping note: Product will be shipped separately from other products purchased in the same order.
  • Storage Conditions:

    -80ºC
  • Notes:

    For corresponding PFFs, see catalog# SPR-317
  • Protein Length:

    Full Length
  • Background Reference 01:

    1. “Genetics Home Reference: SNCA”. US National Library of Medicine. (2013) . 2. Zhang L., et al. (2008) Brain Res. 1244: 40-52. 3. Alim M.A., et al. (2002) J Biol Chem. 277 (3) : 2112-2117. 4. Kokhan V.S., Afanasyeva M.A., Van'kin G. (2012) Behav. Brain. Res. 231 (1) : 226-230. 5. Spillantini M.G., et al. (1997) Nature. 388 (6645) : 839-840. 6. Mezey E., et al. (1998) Nat Med. 4 (7) : 755-757.
  • Location:

    Cytoplasm | Membrane | Nucleus
  • AA Sequence:

    MDVFMKGLSK AKEGVVAAAE KTKQGVAEAA GKTKEGVLYV GSKTKEGVVH GVATVAEKTK EQVTNVGGAV VTGVTAVAQK TVEGAGSIAA ATGFVKKDQL GKNEEGAPQE GILEDMPVDP DNEAYEMPSE EGYQDYEPEA
  • Immunogen Species:

    Human

MSDS

MSDS Document

View Document